Stuttering Clinical Trial
Official title:
Computerized Based Analysis for Detection and Severity Assessment of Stuttering
Verified date | June 2022 |
Source | Assiut University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational [Patient Registry] |
In the light of previous attempts to design and develop automated and objective measures for automatic speech recognition system that detects disfluent speech and assess its severity, yet fully automated measurement of stuttered speech is not available. This study was triggered by the need to design and develop a simple and reliable computerized tool for identification of stuttering and measurement for its severity. Therefore, the aim of this study is to develop a user interface that can work on windows system for the adopted stuttering recognition model which can be used in clinical practice by physicians and therapists.
Status | Not yet recruiting |
Enrollment | 120 |
Est. completion date | October 1, 2024 |
Est. primary completion date | September 30, 2024 |
Accepts healthy volunteers | |
Gender | All |
Age group | 10 Years to 30 Years |
Eligibility | Inclusion Criteria: 1. Age: from 10 to 30 years old. 2. Gender: both sexes will be included in the study. 3. The participants in the study group suffering from developmental stuttering (stuttering symptoms was of early childhood onset, intermittent course and dated since early childhood) seeking speech therapy 4. Have language aptitudes coping with his or her chronological age. Exclusion Criteria: - 1. Presence of any other speech or language disorders. 2. Mental Retardation. 3. Poor scholastic performances. 4. Presence of any psychiatric or neurologic disorders. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Assiut University |
Andrews G, Craig A, Feyer AM, Hoddinott S, Howie P, Neilson M. Stuttering: a review of research findings and theories circa 1982. J Speech Hear Disord. 1983 Aug;48(3):226-46. Review. — View Citation
Bakker K, Brutten GJ. Speech-related reaction times of stutterers and nonstutterers: diagnostic implications. J Speech Hear Disord. 1990 May;55(2):295-9. — View Citation
Enderby PM, John A. Therapy outcome measures in speech and language therapy: comparing performance between different providers. Int J Lang Commun Disord. 1999 Oct-Dec;34(4):417-29. — View Citation
O'Brian S, Packman A, Onslow M, O'Brian N. Measurement of stuttering in adults: comparison of stuttering-rate and severity-scaling methods. J Speech Lang Hear Res. 2004 Oct;47(5):1081-7. — View Citation
Prasse JE, Kikano GE. Stuttering: an overview. Am Fam Physician. 2008 May 1;77(9):1271-6. Review. — View Citation
Prins D, Ingham RJ. Evidence-based treatment and stuttering--historical perspective. J Speech Lang Hear Res. 2009 Feb;52(1):254-63. doi: 10.1044/1092-4388(2008/07-0111). Epub 2008 Aug 11. Review. Erratum in: J Speech Lang Hear Res. 2009 Apr;52(2):570. — View Citation
SHERMAN D. Clinical and experimental use of the Iowa Scale of Severity of Stuttering. J Speech Hear Disord. 1952 Sep;17(3):316-20. — View Citation
Yairi E. Subtyping stuttering I: a review. J Fluency Disord. 2007;32(3):165-96. Epub 2007 Apr 24. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Assessment of stuttering severity: | using both subjective method as The Arabic version of Stuttering Severity Instrument-3 (ASSI3) for children and adults and objective method asAutomatic detection and severity assessment of stuttering | baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Suspended |
NCT01684657 -
A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Asenapine With Flexible Dosing From 5mg to 20mg in Adults With Developmental Stuttering
|
Phase 3 | |
Completed |
NCT02288598 -
Enhancing Speech Fluency With Non-invasive Brain Stimulation in Developmental Stuttering
|
N/A | |
Completed |
NCT00001602 -
Genetic Factors Related to Stuttering
|
N/A | |
Active, not recruiting |
NCT04082104 -
Assessment of Stuttering Severity in Adults and Adolescences in Conversational and Narrative Contexts
|
||
Completed |
NCT04580966 -
IBSR Intervention for Adults Who Stutter
|
N/A | |
Recruiting |
NCT00148161 -
Activity of the Auditory Cortex During Speech Perception and Speech Production in Stuttering
|
N/A | |
Recruiting |
NCT05908123 -
Exploring the Nature, Assessment and Treatment of Stuttering
|
N/A | |
Completed |
NCT00001551 -
Characteristics of Idiopathic Familial Speech Disorders
|
N/A | |
Withdrawn |
NCT01315730 -
The Effects of Tactile Speech Feedback on Stuttering Frequency
|
Phase 1 | |
Completed |
NCT00004991 -
Study of Brain Activity During Speech Production and Speech Perception
|
N/A | |
Recruiting |
NCT05286151 -
Network Connectivity and Temporal Processing in Adolescents Who Stutter
|
N/A | |
Completed |
NCT00001604 -
Genetic Linkage Studies of Stuttering
|
||
Recruiting |
NCT00680303 -
Spacing Lidcombe Program Clinic Visits
|
Phase 2 | |
Recruiting |
NCT00709072 -
Follow-up of Children After Stuttering Treatment
|
Phase 2 | |
Completed |
NCT00830154 -
A Study to Assess the Efficacy and Safety of Pagoclone for Adults With Stuttering
|
Phase 2/Phase 3 | |
Completed |
NCT03698539 -
How Stuttering and Gestures Influence the Intelligibility of Individuals With Down Syndrome
|
||
Completed |
NCT04505696 -
Providing Speech Therapy Awareness in Private Schools
|
N/A | |
Recruiting |
NCT04929184 -
Speech Processing in Stuttering
|
N/A | |
Terminated |
NCT00001308 -
Central Mechanisms in Speech Motor Control Studied With H215O PET
|
||
Completed |
NCT01097161 -
Stuttering and Apraxia of Speech: the Efficacy of an Intervention Program
|
N/A |